Superlaminquatro Tablets

Adult dose

Adults aged 15 and older: take 1 tablet once daily

This medication should not be taken by individuals with hypercalcemia, sarcoidosis (a systemic inflammatory disease of unknown origin), or kidney disease. People who have allergic reactions to any of the ingredients in this medication should also avoid it, as should infants under 12 months, patients with kidney stones, and individuals with severe renal failure. During the use of this medication, do not take phosphate, calcium salts, oral tetracycline antibiotics, antacids, and drugs like levodopa together. Women who are currently receiving treatment from a doctor, pregnant or potentially pregnant, breastfeeding, or premature infants and newborns should consult with a doctor or pharmacist before taking this medication. Particularly, caution is needed with the vitamin D component, as it can be transmitted to the baby through breast milk and cause hypercalcemia. Patients with heart or circulatory problems, kidney disorders, hypoproteinemia, or a history of kidney stones should also consult with a specialist before taking this drug. If symptoms such as nausea, vomiting, diarrhea, oral inflammation, decreased appetite, abdominal distension, skin rash, irregular heartbeat, and central nervous system function impairment occur during use, stop taking the medication immediately and consult a specialist. Additionally, prolonged high-dose intake of some components of this medication may lead to nerve damage, blood abnormalities, exacerbation of peptic ulcers, impaired glucose tolerance, liver damage, etc., so caution is required. Overdosage may cause gastrointestinal symptoms, edema, heart problems, and the risk of increased potassium levels in the blood when taken with certain diuretics. If symptoms do not improve during use, it is advisable to consult a specialist within a month. Always adhere to the prescribed dosage and usage, and be aware that the urine may turn yellow upon taking this medication, which can affect clinical test results. It is advisable to avoid tea containing tannins, such as green tea or black tea before and after taking this medication. Finally, this medication should be stored out of reach of children, protected from direct sunlight, and kept in a cool place with low humidity. Additionally, to maintain quality, it is important not to transfer it to another container.

Serious side effects

Cardiac arrest (heart rhythm disturbance)

Mild side effects

Nausea, vomiting, diarrhea, loose stools, stomatitis (oral inflammation), decreased appetite, abdominal distention, red spots, central nervous system function impairment, discomfort in the abdomen, constipation, rash, sensory neuropathy or neurological symptoms, hematological adverse reactions, exacerbation of peptic ulcers, impaired glucose tolerance, hyperuricemia, liver damage, hypernatremia, congestive heart failure, edema, hyperkalemia, yellowing of urine, affecting clinical test results, tannin content in green tea and black tea

This medication should be stored in a tightly sealed container to protect it from air and moisture, ideally at a temperature between 1 and 30 degrees Celsius. Proper storage will help preserve the effectiveness of the drug for a longer period.

Appearance

Brownish-red oval film-coated tablets

Package unit

60 tablets/bottle, 120 tablets/box [60 tablets/bottle × 2]